Nasdaq:US$17.40 (-0.08) | HKEX:HK$27.38 (-0.22) | AIM:£2.64 (+0.1)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 14 Oct 2012

ISSX 2012: Pharmacokinetic/Pharmacodynamic Modeling of Epitinib to Evaluate the Anti-cancer Effect on A431 Tumor Xenograft in Nude Mice